LMWX 60 Enoxaparin 60mg 0.6ml

Get a Price/Quote

MOQ : 10 Pieces

LMWX 60 Enoxaparin 60mg 0.6ml Specification

Indication
Prevention and treatment of deep vein thrombosis, pulmonary embolism, and in certain cases of acute coronary syndrome

Dosage Form
Injection

Salt Composition
Enoxaparin Sodium

Feature
Ready-to-use prefilled syringe, sterile, single-use

Ingredients
Enoxaparin Sodium 60 mg in 0.6 ml solution

Application
Anticoagulant therapy in medical and surgical patients

Physical Color/Texture
Clear or pale yellow solution

Storage Instructions
Store below 25C, protect from light

Shelf Life
24 months from manufacture

Safety Information
Do not use in cases of active major bleeding, thrombocytopenia, or hypersensitivity to enoxaparin or heparin derivatives

Route of Administration
Subcutaneous Injection

Strength
60 mg / 0.6 ml

Prescription Required
Yes

Pack Type
Prefilled Syringe

Brand Name
LMWX 60

Regulatory Approvals
Available in Canada, EU, UK, USA, Australia

LMWX 60 Enoxaparin 60mg 0.6ml About

Discover the featured LMWX 60 Enoxaparin 60mg 0.6ml, a select and polished anticoagulant solution designed for the prevention and treatment of deep vein thrombosis, pulmonary embolism, and certain acute coronary syndromes. Presented in a ready-to-use, sterile, prefilled syringe, this masterful formulation ensures therapeutic precision and convenience. Approved in Canada, EU, UK, USA, and Australia, LMWX 60 is available for a limited time through prescription. Enlightened safety standards and a shelf life of 24 months ensure quality for medical and surgical patients seeking advanced excellence.

Key Users, Features & Usage Type of LMWX 60 Enoxaparin 60mg 0.6ml

LMWX 60 Enoxaparin 60mg 0.6ml is widely used by healthcare professionals, including doctors and clinical staff, for anticoagulant therapy in both medical and surgical settings. Its standout features include a ready-to-use, sterile, single-use prefilled syringe, offering reliability and ease during administration. The solution is clear or pale yellow, streamlined for subcutaneous injection. This select product ensures accurate dosing and is indicated for adults needing prevention or treatment of blood clots and related conditions.

Arrival Details, Export Markets & Sample Charges for LMWX 60 Enoxaparin 60mg 0.6ml

Expect prompt arrival of LMWX 60 Enoxaparin 60mg 0.6ml to global destinations, with primary export markets including Canada, Europe, the UK, the USA, and Australia. Samples are available upon request, subject to standard charges aligned with the asking price for evaluation purposes. With efficient logistics and secure packaging, distributors and buyers can anticipate consistent supply, supporting smooth import processes and timely delivery to healthcare providers around the world.

FAQ's of LMWX 60 Enoxaparin 60mg 0.6ml:

Q: How is LMWX 60 Enoxaparin 60mg 0.6ml administered?

A: LMWX 60 is administered as a subcutaneous injection, typically by a healthcare professional using its ready-to-use prefilled syringe format.

Q: What are the main indications for using LMWX 60 Enoxaparin 60mg 0.6ml?

A: This medicine is indicated for the prevention and treatment of deep vein thrombosis, pulmonary embolism, and, in some cases, acute coronary syndrome.